Abstract
Cancer is one of the main killers threatening human life and health. The exploration of biomarkers that can predict the long-term survival of cancer patients is of great significance for the risk stratification, treatment and prognosis of cancer patients. However, the screening and validation process involving biomarkers is a complicated process. Currently, there are no unified tools for physicians and researchers to explore tumor biomarkers. Herein, we present CBioExplorer (Cancer Biomarker Explorer), a user-friendly web server and standalone application that includes 5 major modules (dimensionality reduction, benchmark experiment, prediction model, clinical annotation; and, biological annotation) and integrated a novel R package CuratedCancerPrognosisData that reviewed, curated and integrated the gene expression data and corresponding clinical data of 47,210 clinical samples from 268 gene expression studies of 43 common blood and solid tumors, for screening, validation, and annotation of cancer survival related biomarkers based on 6 machine learning survival learners from molecular level to clinical settings. The web server is available at http://cbioexplorer.znhospital.cn:8383/CBioExplorer/, and the standalone app and source code of CBioExplorer and CuratedCancerPrognosisData can be found at https://github.com/liuxiaoping2020/CBioExplorer or https://gitee.com/liuxiaoping2020/CBioExplorer.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
